TrialJournal of thrombosis and thrombolysis2005

Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction.

Sebastian Szabo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.